The emerging role of percutaneous thermal ablation in the treatment of thoracic malignancies
from Surgical Technology International
Thoracic malignancies pose a significant public health burden in the United States, with primary lung cancer accounting for nearly 25% of cancer deaths each year. Percutaneous thermal ablation for the treatment of lung cancer has evolved from a novel oncologic strategy in the 1970s.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063